Xvivo Perfusion AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0004840718
SEK
178.90
6.5 (3.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
822.41
597.54
415.29
258.39
179.86
220.84
187.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
822.41
597.54
415.29
258.39
179.86
220.84
187.87
Raw Material Cost
271.47
180.63
132.02
101.44
59.79
68.38
58.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
278.66
245.06
166.93
122.08
103.73
88.01
63.28
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.60
1.19
1.09
0.28
0.56
0.35
0.00
Selling and Distribution Expenses
322.48
249.16
200.10
130.36
82.24
82.09
69.01
Other Expenses
-17.14
-11.70
-10.33
-9.14
-5.26
-2.86
-1.61
Total Expenditure (Excl Depreciation)
706.82
559.04
396.81
262.76
193.75
210.19
174.35
Operating Profit (PBDIT) excl Other Income
115.60000000000001
38.5
18.5
-4.4
-13.899999999999999
10.600000000000001
13.5
Other Income
117.23
95.75
19.17
31.00
-30.24
-5.01
3.98
Operating Profit (PBDIT)
300.25
165.12
53.46
58.88
-30.76
16.80
24.26
Interest
5.60
1.19
1.09
0.28
0.56
0.35
0.00
Exceptional Items
-27.28
-38.54
-14.25
-19.68
-12.57
0.00
0.00
Gross Profit (PBDT)
550.95
416.91
283.27
156.94
120.07
152.46
129.72
Depreciation
67.42
30.86
15.80
32.26
13.37
11.17
6.77
Profit Before Tax
199.95
94.52
22.31
6.67
-57.26
5.29
17.50
Tax
27.77
2.70
3.89
-1.49
-13.53
0.35
4.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
172.18
91.82
18.43
8.15
-43.73
4.94
12.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
172.18
91.82
18.43
8.15
-43.73
4.94
12.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
172.18
91.82
18.43
8.15
-43.73
4.94
12.69
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,156.78
1,945.05
1,430.14
1,285.45
1,008.46
577.52
540.48
Earnings per share (EPS)
5.44
3.07
0.62
0.28
-1.61
0.18
0.48
Diluted Earnings per share
5.44
3.07
0.62
0.28
-1.61
0.18
0.48
Operating Profit Margin (Excl OI)
14.06%
6.44%
4.45%
-1.69%
-7.72%
4.82%
7.19%
Gross Profit Margin
32.51%
20.98%
9.18%
15.06%
-24.4%
7.45%
12.92%
PAT Margin
20.94%
15.37%
4.44%
3.15%
-24.32%
2.24%
6.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 37.64% vs 43.87% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 87.58% vs 398.91% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 163.69% vs 102.33% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 366.67% vs 9.09% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Xvivo Perfusion AB With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
822.41
2,056.00
-1,233.59
-60.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
822.41
2,056.00
-1,233.59
-60.00%
Raw Material Cost
271.47
939.00
-667.53
-71.09%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
278.66
803.00
-524.34
-65.30%
Power Cost
0
0
0.00
Manufacturing Expenses
5.60
43.00
-37.40
-86.98%
Selling and Distribution Expenses
322.48
664.00
-341.52
-51.43%
Other Expenses
-17.14
-74.50
57.36
76.99%
Total Expenditure (Excl Depreciation)
706.82
1,704.00
-997.18
-58.52%
Operating Profit (PBDIT) excl Other Income
115.60
352.00
-236.40
-67.16%
Other Income
117.23
120.00
-2.77
-2.31%
Operating Profit (PBDIT)
300.25
657.00
-356.75
-54.30%
Interest
5.60
43.00
-37.40
-86.98%
Exceptional Items
-27.28
-101.00
73.72
72.99%
Gross Profit (PBDT)
550.95
1,117.00
-566.05
-50.68%
Depreciation
67.42
185.00
-117.58
-63.56%
Profit Before Tax
199.95
328.00
-128.05
-39.04%
Tax
27.77
44.00
-16.23
-36.89%
Provisions and contingencies
0
0
0.00
Profit After Tax
172.18
284.00
-111.82
-39.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
172.18
284.00
-111.82
-39.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
172.18
284.00
-111.82
-39.37%
Equity Capital
0
0
0.00
Face Value
0.00
1.39
0.00
Reserves
2,156.78
4,113.00
-1,956.22
-47.56%
Earnings per share (EPS)
5.44
3.55
1.89
53.24%
Diluted Earnings per share
5.44
3.55
1.89
53.24%
Operating Profit Margin (Excl OI)
14.06%
17.12%
0.00
-3.06%
Gross Profit Margin
32.51%
24.95%
0.00
7.56%
PAT Margin
20.94%
13.81%
0.00
7.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 82.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 37.64% vs 43.87% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 17.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 87.58% vs 398.91% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 163.69% vs 102.33% in Dec 2023

Annual - Interest
Interest 0.56 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 366.67% vs 9.09% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.06%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023